PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8021908-2	1994	Therapeutic efficacy of nifedipine was confirmed in 69% of the patients and resulted in reduction of SBP by 20.9% and DBP by 19.0% of their initial values, from 179.7/101.3 to 142.1/82.9 mmHg (p < 0.001).	Nifedipine	24-34	selenium binding protein 1	Homo sapiens	101-104	
25956918-12	2015	Nifedipine GITS combination treatment provided mean SBP/DBP changes of -36.1/-18.8 mm Hg in all patients, -40.2/-21.5 mm Hg in previously untreated patients, and -35.6/-18.4 mm Hg in previously treated patients, with similar BP reductions irrespective of the number of concomitant diseases.	Nifedipine	0-10	selenium binding protein 1	Homo sapiens	52-55	
25956918-15	2015	CONCLUSIONS: Combination therapy with nifedipine GITS in a real-life observational setting was highly effective in reducing SBP/DBP in a range of hypertensive patients, with low rates of treatment-related AEs.	Nifedipine	38-48	selenium binding protein 1	Homo sapiens	124-127	
7752176-3	1995	Nifedipine and furosemide reduced blood pressure to the same extent (-14 to -15 mm Hg for supine SBP and -9 to -10 mm Hg for supine DBP, both P < 0.0001).	Nifedipine	0-10	selenium binding protein 1	Homo sapiens	97-100	
9972377-2	1999	METHODS: Patients of the Outpatient Clinic of Cheyenne Veterans Affairs Medical Center, Wyoming, receiving nifedipine ER for the management of hypertension (systolic BP or SBP > 140 mm Hg and diastolic BP or DBP > 90 mm Hg), participated in this study.	Nifedipine	107-117	selenium binding protein 1	Homo sapiens	172-175	
7595908-4	1995	In study 2, verapamil and nifedipine significantly and similarly reduced office DBP and SBP in patients with mild to moderate hypertension.	Nifedipine	26-36	selenium binding protein 1	Homo sapiens	88-91	
7753427-5	1994	Nifedipine reduced SBP and DBP by respectively 6.5% and 13.1% at 8 am and 5.3% and 9.4% at 8 pm.	Nifedipine	0-10	selenium binding protein 1	Homo sapiens	19-22	
3221006-6	1988	The effect of nifedipine was more pronounced on the DBP than on the SBP, and greater reductions of both pressures were achieved in the cases with higher initial readings.	Nifedipine	14-24	selenium binding protein 1	Homo sapiens	68-71	
8207740-8	1994	In the nifedipine group, there was also a significant decrease in SBP and DBP (161 +/- 18 to 139 +/- 5 mmHg, systolic, P < 0.01; 101 +/- 6 to 88 +/- 9 mmHg diastolic, P < 0.05) but with a significant increase in heart rate (79 +/- 14 to 91 +/- 10 beats/minute, P < 0.05).	Nifedipine	7-17	selenium binding protein 1	Homo sapiens	66-69	
8029126-8	1994	Nifedipine caused a significant fall in SBP and DBP (p < 0.001) and a marked increase in HR (p < 0.001).	Nifedipine	0-10	selenium binding protein 1	Homo sapiens	40-43	
1687786-4	1991	Nifedipine produced no significant changes in HR and cardiac output (CO) at rest, but augmented the increase in HR (delta HR) and SBP (delta SBP) during submaximal exercise.	Nifedipine	0-10	selenium binding protein 1	Homo sapiens	112-144	
2657058-4	1989	Nifedipine produced a greater orthostatic effect, and hence a significantly greater fall in erect SBP than felodipine (P less than 0.05).	Nifedipine	0-10	selenium binding protein 1	Homo sapiens	98-101